Belanoff Joseph K's Form 4 filing
Corcept Therapeutics Inc (CORT) · filed Jul 8, 2022
- Accession no.
- 0000899243-22-025827
- Filed
- Jul 8, 2022
- Trade date
- Jul 6-7, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions and 1 derivative transaction. Open-market sales total $8.80M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Belanoff Joseph KCIK 0001286199 | Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 6, 2022 | Common Stock | MOption exerciseAcquired | +800,000 | $2.08 | +$1,664,000 | 800,000 | Direct | |
| Jul 6, 2022 | Common Stock | FTax withholdingDisposed | −451,189 | $26.21 | −$11,825,663.69 | 348,811 | Direct | |
| Jul 6, 2022 | Common Stock | SSaleDisposed | −279,908 | $26.27F3 | −$7,353,183.16 | 2,538,218 | Indirect | |
| Jul 7, 2022 | Common Stock | SSaleDisposed | −55,111 | $26.26F4 | −$1,447,214.86 | 2,483,107 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 6, 2022 | Common Stock | MOption exerciseAcquired | +800,000 | $0.00 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F3
Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $26.21 to $26.65. Information on the exact number of shares sold at each sale price can be obtained from the issuer upon request.
Referenced by the price of 1 transaction in Table I.
- F4
Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $26.21 to $26.41. Information on the exact number of shares sold at each sale price can be obtained from the issuer upon request.
Referenced by the price of 1 transaction in Table I.
Remarks
The power of attorney under which this form was signed is on file with the Commission.